NCT03334838View on ClinicalTrials.gov

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

November 7, 2019

Study Completion Date

January 29, 2020

Conditions
Chagas' Disease
Interventions
DRUG

Nifurtimox (Lampit, BAYA2502)

Oral Intake of 4 x 30 mg nufurtimox tablets for treatment A-D; Oral Intake of 8 x 30 mg nufurtimox tablets for treatment E.

Trial Locations (1)

C1431CEF

FP Clinical Pharma, Buenos Aires

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY